Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
41
DNA Quote, Financials, Valuation and Earnings
Last price:
$8.92
Seasonality move
:
-29.11%
Day range:
$8.54 - $8.98
52-week range:
$5.00 - $17.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.70x
P/B ratio:
0.96x
Volume:
464.9K
Avg. volume:
1M
1-year change:
-4.91%
Market cap:
$539.9M
Revenue:
$227M
EPS (TTM):
-$6.23
Earnings Data
Next earnings date for DNA
Feb 24
2026
Most recent earnings per share
-$1.45
Missed by $1.45
(Nov 6/2025)
Consensus Estimate
--
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DNA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/24/2026 | Q4 | $37.7M | -- | -- | -- | -- |
| 11/06/2025 | Q3 | $38.9M | $38.8M | -$1.45 | -- | -- |
| 08/07/2025 | Q2 | $41.6M | $49.6M | -$1.10 | -- | -- |
| 05/06/2025 | Q1 | $38.7M | $48.3M | -$1.68 | -- | -- |
| 02/25/2025 | Q4 | $44.4M | $43.8M | -$2.00 | -$1.30 | -$0.70 |
| 11/12/2024 | Q3 | $45M | $89M | -$1.08 | -- | -- |
| 08/08/2024 | Q2 | $43M | $56.2M | -$4.23 | -- | -- |
| 05/09/2024 | Q1 | $46M | $37.9M | -$3.31 | -$3.20 | -$0.11 |
| 02/29/2024 | Q4 | $42.6M | $34.8M | -$4.28 | -$2.80 | -$1.48 |
| 11/08/2023 | Q3 | $48.1M | $55.4M | -$6.21 | -$3.20 | -$3.01 |
| 08/09/2023 | Q2 | -- | $80.6M | -$3.59 | -- | -- |
| 05/10/2023 | Q1 | -- | $80.7M | -$4.29 | -- | -- |
| 03/01/2023 | Q4 | -- | $98.3M | -$3.81 | -- | -- |
| 11/14/2022 | Q3 | -- | $66.4M | -$16.44 | -- | -- |
| 08/15/2022 | Q2 | -- | $144.6M | -$16.51 | -- | -- |
| 05/16/2022 | Q1 | -- | $168.4M | -$14.69 | -- | -- |
| 03/28/2022 | Q4 | -- | $148.5M | -$39.73 | -- | -- |
| 11/15/2021 | Q3 | -- | $77.6M | -$2.74 | -- | -- |
| 06/30/2021 | Q2 | -- | $43.6M | -$1.67 | -- | -- |
| 03/31/2021 | Q1 | -- | $44.1M | -$2.28 | -- | -- |
| 12/31/2020 | Q4 | -- | $32.1M | -$1.46 | -- | -- |
| 09/30/2020 | Q3 | -- | $13.3M | -$0.70 | -- | -- |
Ginkgo Bioworks Holdings, Inc. Earnings Questions
-
How Much did Ginkgo Bioworks Holdings, Inc. Generate in Revenue Last Quarter?
Ginkgo Bioworks Holdings, Inc. reported $38.8M worth of top line sales in its most recent quarter.
-
Did Ginkgo Bioworks Holdings, Inc. Beat Earnings Last Quarter?
Ginkgo Bioworks Holdings, Inc. announced earnings per share of -$1.45 which represents a miss of analyst forecast a -- per share.
-
Is Ginkgo Bioworks Holdings, Inc. Profitable?
Ginkgo Bioworks Holdings, Inc. reported $11.9M that represents $0.21 per share over the last quarter.
-
What is the Analyst Consensus for Ginkgo Bioworks Holdings, Inc. EPS Next Year?
Ginkgo Bioworks Holdings, Inc.'s earnings are forecast to decrease from -$10.54 per share to -$9.92 per share next year representing a decrease of -45.99%.
-
When is Ginkgo Bioworks Holdings, Inc.'s Earnings Date?
Ginkgo Bioworks Holdings, Inc.'s next earnings date is February 24, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
